TFF Pharmaceuticals Receives Notice of Allowance for New Foundational Patent Broadly Covering Novel Inhaled Dry Powder Drug Delivery Platform

AUSTIN, Texas, July 11, 2018 /PRNewswire/ — TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions, announced today the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application…Read More

Contact Us

Let us know if you would like more information about TFF
  • This field is for validation purposes and should be left unchanged.